Cover Image

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs

The almost empty armamentarium to treat schistosomiasis, a neglected parasitic disorder caused by trematode flatworms of the genus Schistosoma, except Praziquantel (PZQ), urged to find new alternatives to fight this infection. Carbonic Anhydrase from Schistosoma mansoni (SmCA) is a possible new targ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrea Angeli (Author), Marta Ferraroni (Author), Fabrizio Carta (Author), Cécile Häberli (Author), Jennifer Keiser (Author), Gabriele Costantino (Author), Claudiu T. Supuran (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo
by: Dina M. Metwally, et al.
Published: (2018)

Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase
by: Linda J. Urbanski, et al.
Published: (2020)

Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.
by: Jennifer Keiser, et al.
Published: (2009)

Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives
by: Deepak Shilkar, et al.
Published: (2023)

In vitro antischistosomal activity of Artemisia annua and Artemisia afra extracts
by: Lorencia Taljaard, et al.
Published: (2022)

Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides
by: Linda J. Urbański, et al.
Published: (2021)

Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties
by: Kalyan K. Sethi, et al.
Published: (2021)

Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors
by: Özlen Güzel-Akdemir, et al.
Published: (2018)

Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine.
by: Alexander B Taylor, et al.
Published: (2015)

Diversely N-substituted benzenesulfonamides dissimilarly bind to human carbonic anhydrases: crystallographic investigations of N-nitrosulfonamides
by: Andrea Angeli, et al.
Published: (2023)

Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
by: Daniela Vullo, et al.
Published: (2018)

Antischistosomal, antionchocercal and antitrypanosomal potentials of some Ghanaian traditional medicines and their constituents.
by: Emmanuella Bema Twumasi, et al.
Published: (2020)

Orally active antischistosomal early leads identified from the open access malaria box.
by: Katrin Ingram-Sieber, et al.
Published: (2014)

Escherichia coli γ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors
by: Sonia Del Prete, et al.
Published: (2020)

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
by: Jennifer Keiser, et al.
Published: (2014)

Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273
by: Tanvi V. Wani, et al.
Published: (2018)

Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells
by: Ismail Koyuncu, et al.
Published: (2018)

Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
by: Ismail Koyuncu, et al.
Published: (2019)

Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid-sulphonamide conjugates
by: Hasan Küçükbay, et al.
Published: (2020)

Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
by: Alessandra Rogato, et al.
Published: (2019)

Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
by: Tatiana Sharonova, et al.
Published: (2022)

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
by: Robert Bergquist, et al.
Published: (2017)

Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species
by: Verônica da Silva Cardoso, et al.
Published: (2018)

Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases
by: Mustafa Durgun, et al.
Published: (2020)

Click chemistry approaches for developing carbonic anhydrase inhibitors and their applications
by: Andrea Angeli, et al.
Published: (2023)

Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides
by: Simona Maria Monti, et al.
Published: (2018)

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
by: Nader S. Abutaleb, et al.
Published: (2022)

Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties
by: Sinan Bilginer, et al.
Published: (2020)

Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile
by: Nabih Lolak, et al.
Published: (2020)

New peptide derived antimalaria and antimicrobial agents bearing sulphonamide moiety
by: D. I. Ugwuja, et al.
Published: (2019)

2-((1H-Benzo[d]imidazol-2-yl)amino)benzo[d]thiazole-6-sulphonamides: a class of carbonic anhydrase II and VII-selective inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

Dioxygen, an unexpected carbonic anhydrase ligand
by: Marta Ferraroni, et al.
Published: (2018)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
by: Beatrice Barda, et al.
Published: (2016)

Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides
by: Morteza Abdoli, et al.
Published: (2017)

Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action
by: Marco Bragagni, et al.
Published: (2017)

Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes
by: Petar Žuvela, et al.
Published: (2018)

Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action
by: Mehmet Oguz, et al.
Published: (2020)

Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines
by: Silvia Mussi, et al.
Published: (2022)

Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni.
by: Julien Portela, et al.
Published: (2012)

Design, synthesis, and molecular docking of cysteine-based sulphonamide derivatives as antimicrobial agents
by: Melford C Egbujor, et al.
Published: (2022)